ALFA FinderBSE filing, NSE: INTERCONTINENTAL. Summary written from the filing by ALFA Finder's alert engine.
Medico Intercontinental Ltd: key numbers
- Share price
- ₹27.00
- Market cap
- ₹27.00 Cr
- Revenue (annual)
- ₹84.08 Cr
- Net profit (annual)
- ₹-11.09 Cr
- P/E (TTM)
- -16.1×Sector 46.8×
- Promoter holding
- 58.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Intercontinental Ltd
All →Medico Intercontinental Q2 FY27 Results: Net Profit ₹0 Cr
Medico Intercontinental Ltd reported revenue from operations of ₹22.8 Cr (+11.8% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Medico Intercontinental Board Meeting Date
Medico Intercontinental has scheduled a board meeting for November 6, 2026 to consider unaudited financial results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
Medico Intercontinental Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Limited conducted its 42nd Annual General Meeting on September 30, 2026. Shareholders considered the adoption of FY26 financial statements and approved several related party transactions.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4 Cr
Other board meeting outcome announcements
All →Shri Keshav Cements & Infra Board Meeting Outcome
Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.
Balmer Lawrie Investments Board Meeting Outcome
Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.
- Execution
- FY 2026-27
Jiwanram Sheoduttrai Industries Board Meeting Outcome
Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.
Finolex Cables Board Meeting Outcome
Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).
Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.
BCC Fuba India Board Meeting Outcome
BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.